Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease
Korean Journal of Ophthalmology · 05.10.2023 · 37 (5) · 409-416
DOI: 10.3341/kjo.2023.0062 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Korean Journal of Ophthalmology, erschienen am 05.10.2023. Verfasst von Moonjung Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Korea. Hauptthemen laut MEDLINE: Tears, Dry Eye Syndromes, Matrix Metalloproteinase 9. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health Insurance Service.
Abstract (Originalsprache)
Purpose
To evaluate and compare the clinical efficacy of matrix metalloproteinase-9 (MMP-9) immunoassay and tear osmolarity measurement in diagnosing dry eye severity.
Methods
Dry eye disease (DED) patients underwent diagnostic tests including MMP-9 assay, tear osmolarity measurement, fluorescein tear breakup time, ocular surface staining, anesthetized Schirmer test, Ocular Surface Disease Index questionnaire, and slit-lamp examination. The dry eye parameters were compared according to positive MMP-9 status and increased tear osmolarity. The correlation between dry eye profiles and MMP-9 positivity and high tear osmolarity was also analyzed.
Results
Those who tested positive in MMP-9 immunoassay had significantly higher corneal fluorescein staining score and worse DED severity than those who tested negative. The intensity of MMP-9 positivity showed positive correlation with the corneal staining score and DED severity. However, DED patients with high tear osmolarity above 308 mOsm/L did not show significantly different dry eye signs and symptoms compared to those with lower tear osmolarity values. Tear osmolarity was associated with ocular surface staining score in severe DED patients.
Conclusions
MMP-9 positivity was associated with ocular surface staining and worse dry eye severity. Therefore, it may be used as a useful indicator of disease severity in conjunction to other diagnostic tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
- Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.
- Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea.
Förderung
- National Health Insurance Service
Zitieren
APA
Choi, M., Park, Y. M., & Ko, B. Y. (2023). Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease. Korean Journal of Ophthalmology, 37(5), 409-416. https://doi.org/10.3341/kjo.2023.0062
Vancouver
Choi M, Park YM, Ko BY. Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease. Korean Journal of Ophthalmology. 2023;37(5):409-416. doi:10.3341/kjo.2023.0062
BibTeX
@article{Choi2023,
author = {Choi, Moonjung and Park, Young Min and Ko, Byung Yi},
title = {Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease},
journal = {Korean Journal of Ophthalmology},
year = {2023},
volume = {37},
number = {5},
pages = {409--416},
doi = {10.3341/kjo.2023.0062}
}
EUVIMED